Skip to content
All news
General

Greg Abel Cashes Out on UnitedHealth: Is the Stock a Steal?

Greg Abel, CEO of Berkshire Hathaway and Warren Buffett's successor, sold his shares in UnitedHealth Group. This move comes after Buffett bought shares last year, raising questions about the stock's current valuation.

July 13, 2026
2 min read
Source: Motley Fool
Share:

Greg Abel, the CEO of Berkshire Hathaway and Warren Buffett's designated successor, has sold his shares in UnitedHealth Group (UNH), the healthcare insurance giant. The sale follows Buffett's purchase of the stock last year, prompting speculation about Abel's view on the company's valuation.

Details of the Sale

The exact number of shares sold and the price at which Abel executed the trade have not been disclosed. However, insider selling by a top executive like Abel is often interpreted as a potential signal that the stock may be overvalued.

Context

Warren Buffett's purchase of UnitedHealth shares last year had drawn investor attention. Abel's sale now could indicate a shift in outlook. UnitedHealth faces increasing regulatory scrutiny and margin pressures in the current healthcare environment.

What It Means for Investors

While Abel's sale might be seen as a negative signal, it is important to note that personal trading decisions may not reflect the company's fundamentals. Investors should analyze UnitedHealth's financials and industry trends before making any investment decisions.

Frequently Asked Questions

Greg Abel is the CEO of Berkshire Hathaway and Warren Buffett's designated successor to run the company.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.